Khan AM, Dvorak K, Zhao Q, Bumma N, Cottini F, Devarakonda S, Umyarova E, Sharma N, Benson D, Rosko A. Modified carfilzomib dosing is associated with improved treatment responses and longer time on treatment in patients with multiple myeloma. Haematologica 2023;108(12):3477-3479; https://doi.org/10.3324/haematol.2022.282521.